Document is current
Any future updates will be listed below
-
Authors
Wunderle, Carla
Martin, Elisabeth
Wittig, Alma
Tribolet, Pascal
Lutz, Thomas A.
Köster-Hegmann, Christina
Stanga, Zeno
Mueller, Beat
Schuetz, Philipp
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PP00P3_150531)
Forschungsrat des Kantonsspitals Aarau (1410.000.058)
- License Information
-
More Information
Article History
Received: 9 December 2024
Accepted: 31 March 2025
First Online: 24 April 2025
Declarations
:
: The Ethics Committee of Northwestern/Central Switzerland (EKNZ; 2014_001) approved the study protocol. All participants or their authorized representatives provided written informed consent. The trial was registered at ClinicalTrials.gov ().
: Informed consent for participation and publication was obtained from all participants included in the study. All authors read and approved the final version of the manuscript. All authors confirm, they had full access to all data in this secondary analysis. All authors accept responsibility for the decision to submit for publication.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: PS reports a relationship with Roche, Thermo Fisher, bioMérieux, Nestlé Health Science and Abbott Nutrition that includes: funding grants. ZS reports a relationship with Nestlé Health Science, Fresenius Kabi and B. Braun that includes: funding grants. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
